Home▸Articles▸AI/ML Drug Discovery Infrastructure

REINVENT: Policy-Gradient Molecule Generation

A cutting-edge approach in artificial intelligence for drug discovery that leverages reinforcement learning to optimize molecular structures.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is REINVENT?

REINVENT (Reinforcement Learning-based INventor of Novel Entities for Therapeutics) is a machine learning framework designed to generate drug-like molecules. It operates by treating the molecule generation process as an optimization problem where the policy learns to produce molecules that meet specific criteria.

The key innovation in REINVENT lies in its use of reinforcement learning, particularly the policy gradient method, which allows the model to learn from the outcomes of each generated molecule and adjust its strategy accordingly.

How Does It Work?

In REINVENT, molecules are represented as sequences of tokens (atoms) that can be added or removed in a step-by-step process. The policy network learns to choose the next token based on the current state and the goal defined by the target pocket size and heteroatom balance.

The model is trained using the REINFORCE algorithm, which updates the policy based on the cumulative score of the molecules generated over multiple batches. This ensures that the policy gradually improves its ability to generate molecules with desired properties.

live demo · related simulation● LIVE

Why It Matters

REINVENT represents a significant advancement in drug discovery by automating the molecule generation process, which is traditionally a labor-intensive and time-consuming task.

By optimizing for specific molecular properties such as size and heteroatom balance, REINVENT can help researchers quickly identify promising drug candidates that might otherwise be overlooked.

Real-World Applications

REINVENT has the potential to accelerate the drug discovery process by generating large numbers of novel molecules for testing. This can lead to faster development of new drugs and treatments for various diseases.

Moreover, its ability to optimize molecules based on specific criteria makes it a valuable tool in the design of targeted therapies, where precise control over molecular properties is crucial.

Frequently asked questions

What are policy gradients?

Policy gradients are a class of reinforcement learning algorithms that directly optimize the policy (the strategy) by computing the gradient of the expected reward with respect to the parameters of the policy network.

How does REINVENT differ from other machine learning approaches in drug discovery?

REINVENT uses a token-by-token approach and reinforcement learning, allowing it to generate molecules that are optimized for specific criteria. Other methods might rely on simpler representations or different optimization strategies.

Can REINVENT generate any type of molecule?

REINVENT is specifically designed for generating drug-like molecules, which means the generated molecules will have properties suitable for potential use in pharmaceuticals.

What are some challenges in using REINVENT for drug discovery?

Challenges include ensuring that the policy learns to generate diverse and valid molecular structures, as well as balancing the computational resources required for training with the need for rapid iteration.

Try it live

Everything above runs in your browser — open REINVENT: Policy-Gradient Molecule Generation and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open REINVENT: Policy-Gradient Molecule Generation simulation

What did you find?

Add reproduction steps (optional)